StockData
CannaPharmaRx, Inc. logo

CannaPharmaRx, Inc. (CPMD) stock

CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 1/30
$0.00+0.00 (0.00%)

Close on Oct 16, 2026Market cap $2.54MP/E –Yield –

CannaPharmaRx free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

CannaPharmaRx's free cash flow for the twelve months ending Dec 31, 2025 was -$794.62K. For fiscal 2025 it was -$794.62K. The highest annual figure on record is -$22.38K in fiscal 2016.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$794.62K–
FY2024Dec 31, 2024-$1.70M–
FY2023Dec 31, 2023-$2.36M–
FY2022Dec 31, 2022-$1.56M–
FY2019Dec 31, 2019-$3.80M–
FY2018Dec 31, 2018-$941.14K–
FY2016Dec 31, 2016-$22.38K–
FY2015Dec 31, 2015-$2.55M–
FY2014Dec 31, 2014-$1.64M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$167.24K–
Q4 FY2025Dec 31, 2025$1.06M–
Q3 FY2025Sep 30, 2025-$802.70K–
Q4 FY2024Dec 31, 2024-$179.89K–
Q3 FY2024Sep 30, 2024-$540.90K-551.9%
Q2 FY2024Jun 30, 2024-$427.62K–
Q1 FY2024Mar 31, 2024-$548.83K–
Q4 FY2023Dec 31, 2023-$1.31M–
Q3 FY2023Sep 30, 2023$119.70K–
Q2 FY2023Jun 30, 2023-$555.98K–
Q1 FY2023Mar 31, 2023-$612.63K–
Q4 FY2022Dec 31, 2022-$1.10M–
Q4 FY2019Dec 31, 2019-$975.39K–
Q4 FY2018Dec 31, 2018-$734.89K–
Q4 FY2016Dec 31, 2016-$1–

More CannaPharmaRx figures

See a number that looks wrong?